CD163 and breast cancer: As CD8 + T cells and myeloid cells make a large part of inflammatory infiltrate in TME, in this study we assessed the state of CD8 + T cells along with CD163 + macrophages and PD-L1 status in a well-characterized cohort of 791 treatment-naïve breast cancer patients [27–29].